Any potential COVID-19 vaccine backed by the Trump administration's "Operation Warp Speed" program is unlikely to receive a green light from regulators any earlier than November or December, given the time needed for a large-scale clinical trial, the National Institutes of Health director said on Thursday.
Dental products maker SmileDirectClub Inc reported an 82% fall in quarterly revenue on Wednesday, as delayed procedures due to coronavirus-led restrictions hurt sales of its aligners, sending its shares down about 6% in extended trade.
Becton Dickinson and Co said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly 9%.
AbbVie Inc on Friday posted a quarterly adjusted profit above estimates as robust sales of its blockbuster arthritis treatment, Humira, helped cushion weak demand for its aesthetic drugs, including Botox, due to the COVID-19 pandemic.
Medical device maker Boston Scientific Corp on Wednesday posted a surprise adjusted quarterly profit and said demand for elective procedures picked up pace in July following an easing of coronavirus-driven restrictions.
Laboratory Corporation of America Holdings said on Tuesday it has the capacity to run about 180,000 molecular tests a day and was delivering results in two-three days, but to maintain the speed it will have to perform below full capacity.
HCA Healthcare Inc reported a surprise quarterly profit on Wednesday, as the U.S. hospital operator saw a gradual pickup in demand for elective surgeries amid easing of coronavirus-led restrictions in some parts of the country.
The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device, helping the company build upon the success of its fastest-growing diabetes product.